Skip to main content
PatientsReferrer
 
Request Appointment
Image
https://www.qscan.com.au/wp-content/uploads/2022/04/Untitled-design-6.png

Dr Chung Mo
Koo

MB BCh BAO, FRANZCR, FAANMS
Radiologist and Nuclear Medicine Specialist
Specialties and interests
  • Nuclear medicine
  • Breast imaging
About

Dr Chung Mo Koo is a dual-trained radiologist and nuclear medicine specialist at Qscan Radiology Clinics. He obtained his medical degree from the Royal College of Surgeons in Ireland and completed his core radiology training in South Australia. He was based at the Royal Adelaide Hospital and rotated through Flinders Medical Centre, Women's & Children's, Royal Darwin and Queen Elizabeth Hospitals. 

Chung Mo undertook subspecialty training in breast imaging at Royal North Shore Hospital and BreastScreen NSW. He completed further specialist training in nuclear medicine at St. Vincent's Hospital Sydney and Royal North Shore Hospital.
 

Fellowships
  • Fellowship of the Royal Australian and New Zealand College of Radiologists (FRANZCR)
  • Fellowship of Australasian Association of Nuclear Medicine Specialists (FAANMS)

News & Articles

 

Rare and Uncommon Cancer PET-CT Medicare Rebate

As of 1 November 2022, Medicare rebates are available for patients suffering from rare and uncommon cancers.

Radiofrequency Ablation (RFA) for managing chronic pain

Radiofrequency ablation (RFA) is an interventional procedure performed by a high trained Radiologist under imaging gu

PSMA PET-CT Medicare Rebate

As of 1 July 2022, Medicare rebates are available for patients suffering from prostate cancer.

Rare and Uncommon Cancer PET-CT Medicare Rebate

As of 1 November 2022, Medicare rebates are available for patients suffering from rare and uncommon cancers.

Radiofrequency Ablation (RFA) for managing chronic pain

Radiofrequency ablation (RFA) is an interventional procedure performed by a high trained Radiologist under imaging gu

PSMA PET-CT Medicare Rebate

As of 1 July 2022, Medicare rebates are available for patients suffering from prostate cancer.